Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01653392 · ClinicalTrials.gov registry record
BioThrax® (Anthrax) Vaccine in Pregnancy Registry
A clinical trial, sponsored by Emergent BioSolutions.
- Completed
- Registry status
- 98
- Enrollment target
NCT01653392 is a clinical trial that has completed, run by Emergent BioSolutions. The registered enrollment target is 98 participants.
The verdict
NCT01653392 has completed, sponsored by Emergent BioSolutions.
- COMPLETED
- Registry status
- 98 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if inadvertent receipt of the BioThrax vaccine during pregnancy is independently associated with adverse maternal, pregnancy, or infant health outcomes.
Interventions
- BIOLOGICAL Observational Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 98 participants |
| Start Date | 2012-07 |
| Est. Completion | 2020-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01653392
The ClinicalTrials.gov registry entry for NCT01653392 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 98 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emergent BioSolutions, which has 34 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Observational Intervention is the first listed.
NCT01653392 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01653392 about?
NCT01653392 is a clinical study titled "BioThrax® (Anthrax) Vaccine in Pregnancy Registry". The purpose of this study is to determine if inadvertent receipt of the BioThrax vaccine during pregnancy is independently associated with adverse maternal, pregnancy, or infant health outcomes.
What is the current status of trial NCT01653392?
This trial is currently completed. The enrollment target is 98 participants. The study started on 2012-07. Estimated completion is 2020-02.
What interventions are being tested in trial NCT01653392?
The interventions under investigation include: Observational Intervention (BIOLOGICAL).
Who is sponsoring clinical trial NCT01653392?
This trial is sponsored by Emergent BioSolutions, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.